SPIRONOLACTONE

SPIRONOLACTONE was reported 142743 times

These side effects are most commonly reported by patients taking SPIRONOLACTONE:

# Side effect Count
0 DYSPNOEA 11078
1 FATIGUE 8762
2 NAUSEA 8345
3 DIARRHOEA 8003
4 ACUTE KIDNEY INJURY 7153
5 DIZZINESS 6673
6 HEADACHE 6414
7 HYPOTENSION 6175
8 OFF LABEL USE 6086
9 DRUG INEFFECTIVE 5550
10 FALL 5362
11 ASTHENIA 5282
12 DEATH 5212
13 VOMITING 5144
14 HYPERKALAEMIA 5096
15 PNEUMONIA 4666
16 CARDIAC FAILURE 4657
17 PAIN 4635
18 MALAISE 4632
19 COUGH 4439
20 DRUG INTERACTION 4071
21 ANAEMIA 3929
22 WEIGHT DECREASED 3897
23 OEDEMA PERIPHERAL 3870
24 RENAL FAILURE 3704
25 CONDITION AGGRAVATED 3655
26 DEHYDRATION 3487
27 ARTHRALGIA 3432
28 DECREASED APPETITE 3310
29 CARDIAC FAILURE CONGESTIVE 3137
30 PYREXIA 3130
31 PRURITUS 3115
32 PAIN IN EXTREMITY 3015
33 WEIGHT INCREASED 2994
34 CHEST PAIN 2941
35 HYPONATRAEMIA 2921
36 RASH 2918
37 ATRIAL FIBRILLATION 2879
38 HYPERTENSION 2839
39 ABDOMINAL PAIN 2708
40 RENAL IMPAIRMENT 2571
41 CONSTIPATION 2551
42 PERIPHERAL SWELLING 2543
43 BACK PAIN 2511
44 URINARY TRACT INFECTION 2446
45 CHRONIC KIDNEY DISEASE 2401
46 ANXIETY 2342
47 CONFUSIONAL STATE 2339
48 INSOMNIA 2320
49 FEELING ABNORMAL 2142
50 SYNCOPE 2128
51 BLOOD CREATININE INCREASED 2119
52 FLUID RETENTION 2114
53 GENERAL PHYSICAL HEALTH DETERIORATION 2114
54 ABDOMINAL PAIN UPPER 2061
55 PRODUCT DOSE OMISSION ISSUE 2007
56 RENAL FAILURE ACUTE 2006
57 GASTROINTESTINAL HAEMORRHAGE 1996
58 GAIT DISTURBANCE 1940
59 MUSCLE SPASMS 1919
60 SOMNOLENCE 1913
61 ASCITES 1912
62 MYOCARDIAL INFARCTION 1859
63 HAEMOGLOBIN DECREASED 1814
64 OEDEMA 1808
65 DEPRESSION 1801
66 BLOOD PRESSURE DECREASED 1777
67 BLOOD PRESSURE INCREASED 1774
68 ABDOMINAL DISTENSION 1763
69 BRADYCARDIA 1762
70 SEPSIS 1724
71 PALPITATIONS 1708
72 CARDIAC DISORDER 1694
73 LOSS OF CONSCIOUSNESS 1662
74 EPISTAXIS 1642
75 BLOOD GLUCOSE INCREASED 1632
76 HYPOKALAEMIA 1624
77 PLEURAL EFFUSION 1594
78 MYALGIA 1580
79 DYSPNOEA EXERTIONAL 1559
80 NASOPHARYNGITIS 1528
81 COVID-19 1522
82 ABDOMINAL DISCOMFORT 1521
83 PRODUCT USE IN UNAPPROVED INDICATION 1503
84 PLATELET COUNT DECREASED 1475
85 OXYGEN SATURATION DECREASED 1450
86 GASTROOESOPHAGEAL REFLUX DISEASE 1435
87 TREMOR 1418
88 ALOPECIA 1409
89 PULMONARY HYPERTENSION 1385
90 DRUG HYPERSENSITIVITY 1382
91 CARDIAC ARREST 1380
92 RESPIRATORY FAILURE 1369
93 MUSCULAR WEAKNESS 1362
94 ERYTHEMA 1331
95 THROMBOCYTOPENIA 1330
96 HEART RATE INCREASED 1323
97 CHEST DISCOMFORT 1322
98 PRODUCT USE ISSUE 1302
99 CEREBROVASCULAR ACCIDENT 1296
100 CONTUSION 1275
101 PULMONARY OEDEMA 1274
102 HOSPITALISATION 1264
103 INFECTION 1261
104 ASTHMA 1221
105 MEMORY IMPAIRMENT 1220
106 INTERNATIONAL NORMALISED RATIO INCREASED 1204
107 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1200
108 HYPOAESTHESIA 1198
109 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1161
110 TACHYCARDIA 1146
111 DISEASE PROGRESSION 1143
112 SWELLING 1141
113 HYPERHIDROSIS 1115
114 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1102
115 FLUSHING 1089
116 BRONCHITIS 1084
117 INFLUENZA 1050
118 ARRHYTHMIA 1046
119 HEPATIC ENCEPHALOPATHY 1044
120 PULMONARY ARTERIAL HYPERTENSION 1035
121 SINUSITIS 1031
122 HYPERSENSITIVITY 1022
123 BLOOD POTASSIUM INCREASED 1014
124 CELLULITIS 1012
125 HEPATIC CIRRHOSIS 1001
126 RENAL DISORDER 996
127 VISION BLURRED 995
128 HEPATIC FAILURE 987
129 HAEMORRHAGE 986
130 JOINT SWELLING 984
131 DYSPEPSIA 983
132 PARAESTHESIA 980
133 TOXICITY TO VARIOUS AGENTS 978
134 PRODUCTIVE COUGH 977
135 INJECTION SITE PAIN 974
136 PULMONARY EMBOLISM 967
137 ILLNESS 964
138 CHILLS 951
139 BLOOD POTASSIUM DECREASED 944
140 INCORRECT DOSE ADMINISTERED 929
141 OROPHARYNGEAL PAIN 912
142 DYSPHAGIA 899
143 VISUAL IMPAIRMENT 890
144 BLOOD UREA INCREASED 889
145 BALANCE DISORDER 887
146 HYPOGLYCAEMIA 882
147 WHEEZING 881
148 DIABETES MELLITUS 880
149 DRY SKIN 864
150 URTICARIA 852
151 EJECTION FRACTION DECREASED 845
152 ASPARTATE AMINOTRANSFERASE INCREASED 837
153 VENTRICULAR TACHYCARDIA 837
154 WHITE BLOOD CELL COUNT DECREASED 831
155 OVERDOSE 824
156 ALANINE AMINOTRANSFERASE INCREASED 817
157 NEUTROPENIA 817
158 DRUG INTOLERANCE 810
159 HYPOXIA 806
160 NASAL CONGESTION 805
161 NEUROPATHY PERIPHERAL 803
162 RIGHT VENTRICULAR FAILURE 796
163 MIGRAINE 785
164 SEPTIC SHOCK 785
165 LETHARGY 774
166 METABOLIC ACIDOSIS 771
167 DRY MOUTH 766
168 PAIN IN JAW 760
169 RHABDOMYOLYSIS 759
170 LIVER DISORDER 750
171 LACTIC ACIDOSIS 742
172 DEEP VEIN THROMBOSIS 736
173 SEIZURE 735
174 HYPOTHYROIDISM 733
175 UNEVALUABLE EVENT 731
176 INTENTIONAL PRODUCT USE ISSUE 721
177 SLEEP APNOEA SYNDROME 721
178 MELAENA 718
179 ORTHOSTATIC HYPOTENSION 712
180 HEART RATE DECREASED 708
181 RHINORRHOEA 706
182 INFUSION SITE PAIN 705
183 BURNING SENSATION 703
184 BLOOD BILIRUBIN INCREASED 702
185 GASTROINTESTINAL DISORDER 702
186 THROMBOSIS 695
187 RECTAL HAEMORRHAGE 692
188 CARDIO-RESPIRATORY ARREST 689
189 PERICARDIAL EFFUSION 683
190 PANCYTOPENIA 681
191 MITRAL VALVE INCOMPETENCE 678
192 CARDIOMEGALY 677
193 ARTHRITIS 670
194 DRUG DOSE OMISSION 669
195 LUNG DISORDER 662
196 BLOOD SODIUM DECREASED 654
197 TREATMENT NONCOMPLIANCE 646
198 HAEMOPTYSIS 645
199 HAEMATOCHEZIA 637
200 INTERSTITIAL LUNG DISEASE 632
201 HEPATIC FUNCTION ABNORMAL 629
202 CORONARY ARTERY DISEASE 628
203 ACUTE MYOCARDIAL INFARCTION 624
204 HALLUCINATION 622
205 HAEMATURIA 615
206 CARDIOMYOPATHY 612
207 THERAPY INTERRUPTED 608
208 HAEMATOMA 606
209 DYSPHONIA 605
210 HOT FLUSH 602
211 CARDIAC FAILURE CHRONIC 599
212 STRESS 596
213 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 595
214 VERTIGO 595
215 HYPERGLYCAEMIA 593
216 FLATULENCE 592
217 SLEEP DISORDER 588
218 MOBILITY DECREASED 584
219 MALIGNANT NEOPLASM PROGRESSION 578
220 THERAPY NON-RESPONDER 578
221 AMNESIA 577
222 RENAL INJURY 575
223 END STAGE RENAL DISEASE 573
224 FLUID OVERLOAD 572
225 ACUTE RESPIRATORY FAILURE 567
226 CATARACT 567
227 INJURY 566
228 ANGINA PECTORIS 561
229 AGITATION 560
230 NECK PAIN 558
231 CARDIOGENIC SHOCK 555
232 URINARY RETENTION 553
233 UPPER RESPIRATORY TRACT INFECTION 552
234 SKIN EXFOLIATION 551
235 GLOMERULAR FILTRATION RATE DECREASED 550
236 HAEMATEMESIS 548
237 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 548
238 ELECTROCARDIOGRAM QT PROLONGED 545
239 PSORIASIS 544
240 JAUNDICE 540
241 POLLAKIURIA 540
242 EMOTIONAL DISTRESS 539
243 UPPER GASTROINTESTINAL HAEMORRHAGE 532
244 THROAT IRRITATION 527
245 DISORIENTATION 523
246 MUSCULOSKELETAL STIFFNESS 521
247 HEPATIC ENZYME INCREASED 511
248 ENCEPHALOPATHY 510
249 PRESYNCOPE 508
250 MUSCULOSKELETAL PAIN 503
251 BLOOD ALKALINE PHOSPHATASE INCREASED 502
252 SWELLING FACE 502
253 WHITE BLOOD CELL COUNT INCREASED 499
254 C-REACTIVE PROTEIN INCREASED 498
255 DYSGEUSIA 498
256 TRICUSPID VALVE INCOMPETENCE 496
257 FEELING HOT 495
258 DEPRESSED LEVEL OF CONSCIOUSNESS 490
259 INFLUENZA LIKE ILLNESS 490
260 HERPES ZOSTER 488
261 BLISTER 487
262 DYSURIA 487
263 CHOLELITHIASIS 485
264 HEAD INJURY 485
265 RESPIRATORY DISTRESS 485
266 RHEUMATOID ARTHRITIS 484
267 GYNAECOMASTIA 480
268 INFLAMMATION 480
269 SPEECH DISORDER 480
270 GOUT 473
271 BONE PAIN 471
272 PANCREATITIS 469
273 INTENTIONAL PRODUCT MISUSE 465
274 GASTRITIS 460
275 MULTIPLE ORGAN DYSFUNCTION SYNDROME 458
276 DELIRIUM 454
277 CARDIAC FAILURE ACUTE 453
278 STOMATITIS 453
279 BLOOD GLUCOSE DECREASED 452
280 TYPE 2 DIABETES MELLITUS 451
281 SKIN ULCER 450
282 SKIN DISCOLOURATION 449
283 DISTURBANCE IN ATTENTION 448
284 FEBRILE NEUTROPENIA 446
285 OSTEOARTHRITIS 446
286 ADVERSE EVENT 442
287 OSTEOPOROSIS 442
288 INFUSION SITE ERYTHEMA 441
289 GAMMA-GLUTAMYLTRANSFERASE INCREASED 438
290 ELECTROLYTE IMBALANCE 437
291 SURGERY 437
292 FIBROMYALGIA 435
293 EYE PAIN 434
294 HYPOPHAGIA 434
295 LIVER FUNCTION TEST ABNORMAL 432
296 HEART RATE IRREGULAR 428
297 GENERALISED OEDEMA 426
298 RESPIRATORY TRACT INFECTION 425
299 PRODUCT QUALITY ISSUE 424
300 PULMONARY CONGESTION 423
301 INJECTION SITE ERYTHEMA 421
302 MENTAL STATUS CHANGES 421
303 TRANSIENT ISCHAEMIC ATTACK 420
304 COGNITIVE DISORDER 418
305 SEASONAL ALLERGY 418
306 RASH PRURITIC 417
307 DISCOMFORT 415
308 TINNITUS 414
309 CARPAL TUNNEL SYNDROME 413
310 CEREBRAL HAEMORRHAGE 413
311 NEPHROLITHIASIS 413
312 UNDERDOSE 412
313 NO ADVERSE EVENT 410
314 STAPHYLOCOCCAL INFECTION 410
315 PRODUCT PRESCRIBING ERROR 408
316 NERVOUSNESS 405
317 ADVERSE DRUG REACTION 404
318 DEVICE ISSUE 404
319 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 397
320 RED BLOOD CELL COUNT DECREASED 396
321 HAEMATOCRIT DECREASED 393
322 MEDICATION ERROR 392
323 BLOOD PRESSURE ABNORMAL 389
324 LEFT VENTRICULAR DYSFUNCTION 389
325 BLOOD TEST ABNORMAL 388
326 CONTRAINDICATED PRODUCT ADMINISTERED 387
327 ORTHOPNOEA 387
328 SHOCK 387
329 COAGULOPATHY 386
330 LEUKOPENIA 385
331 ANGIOEDEMA 383
332 SUICIDAL IDEATION 381
333 COMA 380
334 PRODUCT DOSE OMISSION 380
335 DEVICE DISLOCATION 377
336 VIRAL INFECTION 377
337 URINARY INCONTINENCE 375
338 DYSARTHRIA 374
339 PNEUMONIA ASPIRATION 371
340 DEPRESSED MOOD 370
341 VENTRICULAR FIBRILLATION 370
342 INFUSION RELATED REACTION 369
343 BLOOD PRESSURE FLUCTUATION 365
344 AMMONIA INCREASED 364
345 EOSINOPHILIA 362
346 MULTI-ORGAN FAILURE 362
347 POOR QUALITY SLEEP 361
348 PALLOR 357
349 CEREBRAL INFARCTION 356
350 DIVERTICULITIS 356
351 NEPHROGENIC ANAEMIA 356
352 DEVICE MALFUNCTION 355
353 DRY EYE 355
354 ECZEMA 355
355 AGRANULOCYTOSIS 354
356 HYPOVOLAEMIA 354
357 ATRIOVENTRICULAR BLOCK COMPLETE 353
358 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 353
359 ATRIAL FLUTTER 351
360 CYSTITIS 351
361 BRAIN NATRIURETIC PEPTIDE INCREASED 349
362 HYPERVOLAEMIA 346
363 PRODUCT SUBSTITUTION ISSUE 346
364 BLOOD CHOLESTEROL INCREASED 345
365 RASH ERYTHEMATOUS 345
366 CIRCULATORY COLLAPSE 342
367 HYPOACUSIS 342
368 LIMB INJURY 341
369 TUBULOINTERSTITIAL NEPHRITIS 341
370 CONGESTIVE CARDIOMYOPATHY 340
371 DISEASE RECURRENCE 339
372 GASTRIC ULCER 339
373 HYPOCALCAEMIA 339
374 ISCHAEMIC STROKE 339
375 SKIN DISORDER 339
376 ALTERED STATE OF CONSCIOUSNESS 337
377 IRON DEFICIENCY ANAEMIA 337
378 HYPOMAGNESAEMIA 334
379 RHINITIS ALLERGIC 332
380 SUBDURAL HAEMATOMA 332
381 RESPIRATORY DISORDER 331
382 TOXIC EPIDERMAL NECROLYSIS 330
383 ECONOMIC PROBLEM 329
384 THERAPY CESSATION 329
385 HYPERLIPIDAEMIA 328
386 DRUG-INDUCED LIVER INJURY 326
387 DERMATITIS CONTACT 324
388 ILL-DEFINED DISORDER 324
389 RASH MACULO-PAPULAR 324
390 LOWER RESPIRATORY TRACT INFECTION 323
391 VENTRICULAR EXTRASYSTOLES 320
392 DEVICE RELATED INFECTION 319
393 FAECES DISCOLOURED 319
394 COLITIS 316
395 THERAPEUTIC RESPONSE UNEXPECTED 316
396 ARTHROPATHY 315
397 ATRIOVENTRICULAR BLOCK 315
398 IRRITABILITY 315
399 NEUTROPHIL COUNT DECREASED 315
400 DEMENTIA 312
401 DIZZINESS POSTURAL 312
402 HYPERSOMNIA 312
403 BLOOD CREATINE PHOSPHOKINASE INCREASED 311
404 INJECTION SITE BRUISING 311
405 LYMPHADENOPATHY 310
406 FUNGAL INFECTION 307
407 INTENTIONAL DOSE OMISSION 307
408 BUNDLE BRANCH BLOCK LEFT 306
409 HIP FRACTURE 305
410 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 304
411 ACNE 303
412 BLINDNESS 302
413 ISCHAEMIC CARDIOMYOPATHY 300
414 URINE OUTPUT DECREASED 300
415 HAEMORRHOIDS 299
416 LOCALISED INFECTION 299
417 CARDIAC MURMUR 298
418 FEELING COLD 298
419 STEVENS-JOHNSON SYNDROME 298
420 RIB FRACTURE 297
421 LIP SWELLING 295
422 SINUS BRADYCARDIA 295
423 HYPERTHYROIDISM 294
424 INTESTINAL OBSTRUCTION 293
425 UNRESPONSIVE TO STIMULI 293
426 MENTAL DISORDER 292
427 RESTLESSNESS 289
428 ROAD TRAFFIC ACCIDENT 289
429 RASH MACULAR 287
430 LABORATORY TEST ABNORMAL 286
431 PROTEINURIA 286
432 CYANOSIS 285
433 PANCREATITIS ACUTE 285
434 GAIT INABILITY 284
435 INFUSION SITE SWELLING 284
436 INJECTION SITE HAEMORRHAGE 283
437 LIMB DISCOMFORT 283
438 POLYCYSTIC OVARIES 283
439 GLYCOSYLATED HAEMOGLOBIN INCREASED 282
440 TRANSFUSION 282
441 INJECTION SITE PRURITUS 281
442 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 281
443 OBSTRUCTIVE AIRWAYS DISORDER 281
444 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 280
445 VAGINAL HAEMORRHAGE 280
446 BLOOD PRESSURE SYSTOLIC INCREASED 279
447 PANIC ATTACK 278
448 CLOSTRIDIUM DIFFICILE INFECTION 276
449 CONVULSION 276
450 NEURALGIA 275
451 NEOPLASM MALIGNANT 274
452 POLYURIA 274
453 APHASIA 273
454 DIABETES MELLITUS INADEQUATE CONTROL 271
455 TREATMENT FAILURE 271
456 ANHEDONIA 270
457 RETCHING 269
458 WEIGHT FLUCTUATION 269
459 EYE IRRITATION 267
460 GASTROENTERITIS 267
461 OBESITY 267
462 RALES 267
463 SPLENOMEGALY 267
464 SUBARACHNOID HAEMORRHAGE 266
465 ANAPHYLACTIC REACTION 265
466 HEPATOMEGALY 265
467 PULMONARY MASS 265
468 WOUND 265
469 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 264
470 ELECTROCARDIOGRAM ABNORMAL 264
471 IMPAIRED HEALING 263
472 SKIN LESION 261
473 TACHYPNOEA 261
474 CHOLESTASIS 257
475 DYSSTASIA 257
476 SENSITISATION 257
477 SHOCK HAEMORRHAGIC 257
478 ANURIA 256
479 PRESCRIBED UNDERDOSE 255
480 THERAPEUTIC RESPONSE DECREASED 255
481 EYE SWELLING 254
482 VARICES OESOPHAGEAL 254
483 HEPATIC STEATOSIS 253
484 MUSCLE TWITCHING 253
485 LEUKOCYTOSIS 252
486 CONCOMITANT DISEASE AGGRAVATED 251
487 FULL BLOOD COUNT ABNORMAL 251
488 MYOCARDIAL ISCHAEMIA 251
489 ATELECTASIS 250
490 CHOKING 250
491 CORONARY ARTERY OCCLUSION 250
492 HEPATITIS 250
493 THIRST 250
494 MATERNAL EXPOSURE DURING PREGNANCY 249
495 FEAR 248
496 RENAL FAILURE CHRONIC 248
497 CRYING 247
498 HYPOALBUMINAEMIA 247
499 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 247
500 OCULAR HYPERAEMIA 244
501 OLIGURIA 244
502 CHROMATURIA 243
503 EYE PRURITUS 243
504 FEEDING DISORDER 241
505 INSURANCE ISSUE 241
506 PROTHROMBIN TIME PROLONGED 241
507 DYSKINESIA 240
508 DIPLOPIA 238
509 INJECTION SITE SWELLING 238
510 SUDDEN DEATH 237
511 KIDNEY INFECTION 235
512 NIGHT SWEATS 235
513 HALLUCINATION, VISUAL 233
514 ACCIDENTAL OVERDOSE 232
515 GALLBLADDER DISORDER 231
516 INFUSION SITE HAEMORRHAGE 231
517 MALNUTRITION 231
518 SINUS DISORDER 231
519 ANGINA UNSTABLE 230
520 BREAST CANCER 230
521 HIATUS HERNIA 230
522 NIGHTMARE 230
523 BLOOD ALBUMIN DECREASED 229
524 SWOLLEN TONGUE 229
525 GASTRIC DISORDER 228
526 LEFT VENTRICULAR FAILURE 228
527 UPPER-AIRWAY COUGH SYNDROME 226
528 EJECTION FRACTION 225
529 HYPERBILIRUBINAEMIA 225
530 PEMPHIGOID 225
531 PERIPHERAL COLDNESS 225
532 ABDOMINAL PAIN LOWER 223
533 COMPLETED SUICIDE 223
534 PLASMA CELL MYELOMA 222
535 CROHN^S DISEASE 221
536 LACRIMATION INCREASED 221
537 PURPURA 221
538 HAEMORRHAGIC ANAEMIA 220
539 ORAL PAIN 220
540 DRUG ERUPTION 219
541 JOINT INJURY 219
542 FEMUR FRACTURE 218
543 HAEMOGLOBIN INCREASED 218
544 RESPIRATORY ARREST 218
545 MOVEMENT DISORDER 217
546 RENAL TUBULAR NECROSIS 217
547 AGGRESSION 216
548 LOWER GASTROINTESTINAL HAEMORRHAGE 216
549 LEFT VENTRICULAR HYPERTROPHY 215
550 ACUTE PULMONARY OEDEMA 214
551 GASTROENTERITIS VIRAL 214
552 NEPHROPATHY 214
553 TORSADE DE POINTES 214
554 ATRIOVENTRICULAR BLOCK FIRST DEGREE 213
555 NEOPLASM PROGRESSION 213
556 ACIDOSIS 212
557 DEVICE OCCLUSION 212
558 BLOOD MAGNESIUM DECREASED 211
559 LUNG NEOPLASM MALIGNANT 211
560 SUICIDE ATTEMPT 211
561 FULL BLOOD COUNT DECREASED 210
562 HEPATOCELLULAR CARCINOMA 210
563 HIDRADENITIS 210
564 INTERNAL HAEMORRHAGE 210
565 ACUTE RESPIRATORY DISTRESS SYNDROME 209
566 INTERVERTEBRAL DISC PROTRUSION 209
567 PAIN OF SKIN 209
568 IMPAIRED GASTRIC EMPTYING 207
569 MIDDLE INSOMNIA 207
570 POST PROCEDURAL COMPLICATION 207
571 TRANSAMINASES INCREASED 207
572 DEVICE LEAKAGE 206
573 FREQUENT BOWEL MOVEMENTS 206
574 TROPONIN INCREASED 206
575 ARTERIOSCLEROSIS 205
576 DEAFNESS 205
577 DISSEMINATED INTRAVASCULAR COAGULATION 205
578 EATING DISORDER 204
579 BACTERAEMIA 203
580 DRUG LEVEL INCREASED 203
581 RESPIRATORY TRACT CONGESTION 203
582 AORTIC VALVE INCOMPETENCE 202
583 BLOOD PRESSURE DIASTOLIC DECREASED 202
584 EYE DISORDER 202
585 PRODUCT ADMINISTRATION ERROR 202
586 PRODUCT ADMINISTRATION INTERRUPTED 202
587 MULTIPLE ALLERGIES 201
588 PRODUCT DOSE OMISSION IN ERROR 201
589 PULMONARY FIBROSIS 201
590 SNEEZING 201
591 ACCIDENTAL EXPOSURE TO PRODUCT 199
592 BACTERIAL INFECTION 199
593 BLOOD PRESSURE SYSTOLIC DECREASED 199
594 CARDIOVASCULAR DISORDER 199
595 CLOSTRIDIUM DIFFICILE COLITIS 199
596 RESTLESS LEGS SYNDROME 199
597 SUPRAVENTRICULAR TACHYCARDIA 199
598 THERAPEUTIC AGENT TOXICITY 199
599 AGEUSIA 197
600 BLOOD IRON DECREASED 197
601 BLOOD URIC ACID INCREASED 197
602 BREAST PAIN 197
603 MUSCULOSKELETAL CHEST PAIN 197
604 BODY TEMPERATURE INCREASED 195
605 HYPOKINESIA 195
606 BLOOD COUNT ABNORMAL 194
607 BREATH SOUNDS ABNORMAL 194
608 OESOPHAGEAL VARICES HAEMORRHAGE 194
609 BRASH SYNDROME 193
610 FACE OEDEMA 193
611 TASTE DISORDER 193
612 VASCULAR DEVICE INFECTION 193
613 BRAIN FOG 192
614 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 191
615 CARDIOACTIVE DRUG LEVEL INCREASED 190
616 DERMATITIS ATOPIC 190
617 SINUS TACHYCARDIA 189
618 VENTRICULAR HYPOKINESIA 189
619 VISUAL ACUITY REDUCED 189
620 HEMIPARESIS 188
621 MUSCULOSKELETAL DISCOMFORT 188
622 PNEUMOTHORAX 188
623 BLOOD TRIGLYCERIDES INCREASED 187
624 EXERCISE TOLERANCE DECREASED 187
625 INABILITY TO AFFORD MEDICATION 187
626 RASH PAPULAR 187
627 DRUG PRESCRIBING ERROR 186
628 HEPATOCELLULAR INJURY 186
629 BLOOD URINE PRESENT 185
630 VASCULITIS 185
631 FOETAL EXPOSURE DURING PREGNANCY 184
632 SYSTEMIC LUPUS ERYTHEMATOSUS 184
633 TOXIC SKIN ERUPTION 184
634 ABNORMAL BEHAVIOUR 183
635 PORTAL HYPERTENSION 183
636 ADRENAL INSUFFICIENCY 182
637 LYMPHOCYTE COUNT DECREASED 182
638 PNEUMONITIS 182
639 SKIN LACERATION 182
640 EAR INFECTION 181
641 ORAL CANDIDIASIS 181
642 INJECTION SITE REACTION 180
643 LIVER FUNCTION TEST INCREASED 180
644 MUCOSAL INFLAMMATION 180
645 SPINAL FRACTURE 180
646 TOOTH DISORDER 180
647 PRURITUS GENERALISED 179
648 BUNDLE BRANCH BLOCK RIGHT 178
649 CARDIAC VALVE DISEASE 178
650 HERNIA 178
651 PROCEDURAL PAIN 178
652 HYPERPARATHYROIDISM SECONDARY 177
653 IMPAIRED QUALITY OF LIFE 176
654 POST PROCEDURAL HAEMORRHAGE 176
655 SKIN BURNING SENSATION 176
656 ABASIA 175
657 EOSINOPHIL COUNT INCREASED 175
658 HEPATORENAL SYNDROME 175
659 LIVER INJURY 175
660 SINUS CONGESTION 175
661 CANDIDA INFECTION 174
662 ORAL HERPES 174
663 SCIATICA 174
664 TOOTHACHE 174
665 NOCTURIA 173
666 ANOREXIA 172
667 CHOLECYSTITIS 171
668 EMOTIONAL DISORDER 171
669 RENAL CYST 171
670 BLOOD LACTATE DEHYDROGENASE INCREASED 170
671 DRUG DEPENDENCE 170
672 EAR PAIN 170
673 INTENTIONAL OVERDOSE 170
674 PHOTOSENSITIVITY REACTION 170
675 PRODUCT AVAILABILITY ISSUE 170
676 HEAD DISCOMFORT 169
677 UROSEPSIS 169
678 ARTERIOSCLEROSIS CORONARY ARTERY 168
679 HYPOVOLAEMIC SHOCK 168
680 UPPER LIMB FRACTURE 168
681 SCAR 167
682 ASPIRATION 166
683 DIALYSIS 166
684 EMPHYSEMA 166
685 ERUCTATION 166
686 MYOCLONUS 166
687 ATRIAL TACHYCARDIA 165
688 COLD SWEAT 165
689 LUNG INFILTRATION 165
690 SKIN CANCER 165
691 DEVICE BREAKAGE 164
692 GINGIVAL BLEEDING 164
693 ABSCESS 163
694 ANGER 163
695 BONE DENSITY DECREASED 163
696 DIASTOLIC DYSFUNCTION 163
697 DUODENAL ULCER 163
698 IMPAIRED WORK ABILITY 163
699 EXPOSURE DURING PREGNANCY 162
700 HEPATITIS C 162
701 THERAPY PARTIAL RESPONDER 162
702 ERECTILE DYSFUNCTION 161
703 OSTEOMYELITIS 161
704 OSTEOPENIA 161
705 THROAT TIGHTNESS 161
706 SKIN IRRITATION 160
707 HAEMODYNAMIC INSTABILITY 159
708 HEPATIC NEOPLASM MALIGNANT 159
709 INFUSION SITE INFECTION 159
710 HEPATOTOXICITY 158
711 HYPERCALCAEMIA 158
712 PSORIATIC ARTHROPATHY 158
713 ACTIVITIES OF DAILY LIVING IMPAIRED 157
714 COMPLICATION ASSOCIATED WITH DEVICE 157
715 EJECTION FRACTION ABNORMAL 157
716 FOOT FRACTURE 157
717 IRRITABLE BOWEL SYNDROME 157
718 SEDATION 157
719 MUSCLE TIGHTNESS 156
720 SKIN FISSURES 156
721 DRUG EFFECT DECREASED 155
722 JOINT STIFFNESS 155
723 TOOTH INFECTION 155
724 ANKLE FRACTURE 154
725 CATHETERISATION CARDIAC 154
726 COLITIS ULCERATIVE 154
727 DEVICE INFUSION ISSUE 154
728 DRUG ADMINISTRATION ERROR 154
729 FACIAL PAIN 154
730 MUSCLE ATROPHY 154
731 THYROID DISORDER 154
732 DECUBITUS ULCER 153
733 CONJUNCTIVITIS 152
734 LUNG INFECTION 152
735 OESOPHAGITIS 152
736 BLOOD CREATINE INCREASED 151
737 CARDIAC DYSFUNCTION 151
738 DECREASED ACTIVITY 151
739 DRUG RESISTANCE 151
740 MENTAL IMPAIRMENT 151
741 PERITONITIS 151
742 RASH GENERALISED 151
743 SKIN HAEMORRHAGE 151
744 DERMATITIS 150
745 WRIST FRACTURE 150
746 DYSPNOEA AT REST 149
747 EXTRA DOSE ADMINISTERED 149
748 FLANK PAIN 149
749 HYPERURICAEMIA 149
750 ROTATOR CUFF SYNDROME 149
751 BACK DISORDER 148
752 HAEMODIALYSIS 148
753 HAEMORRHAGE INTRACRANIAL 148
754 PERICARDITIS 148
755 ANAPHYLACTIC SHOCK 147
756 BLOOD GLUCOSE ABNORMAL 147
757 ECCHYMOSIS 147
758 INCONTINENCE 147
759 MOOD SWINGS 147
760 MULTIPLE SCLEROSIS RELAPSE 147
761 PETECHIAE 147
762 COVID-19 PNEUMONIA 146
763 CREATININE RENAL CLEARANCE DECREASED 146
764 EPILEPSY 146
765 LOCALISED OEDEMA 146
766 NERVOUS SYSTEM DISORDER 146
767 RESPIRATORY RATE INCREASED 146
768 ULCER 146
769 INFUSION SITE DISCHARGE 145
770 METASTASES TO LIVER 145
771 VITAMIN D DEFICIENCY 145
772 COLON CANCER 144
773 DIABETIC KETOACIDOSIS 144
774 MOUTH ULCERATION 144
775 MULTIPLE INJURIES 144
776 REBOUND ACID HYPERSECRETION 144
777 BLOOD CALCIUM DECREASED 143
778 BONE DISORDER 143
779 PARALYSIS 143
780 PRE-EXISTING CONDITION IMPROVED 143
781 SEROTONIN SYNDROME 143
782 THERAPEUTIC PRODUCT EFFECT DECREASED 143
783 WRONG TECHNIQUE IN DRUG USAGE PROCESS 143
784 DIVERTICULUM 141
785 AORTIC STENOSIS 140
786 FEELING JITTERY 140
787 FRACTURE 140
788 GLOSSODYNIA 140
789 RESPIRATORY SYNCYTIAL VIRUS INFECTION 140
790 CARDIAC PACEMAKER INSERTION 139
791 GASTRIC HAEMORRHAGE 139
792 GASTRITIS EROSIVE 139
793 HYPERNATRAEMIA 139
794 HYPOTONIA 139
795 PROSTATE CANCER 139
796 SPINAL OSTEOARTHRITIS 139
797 BODY TEMPERATURE DECREASED 138
798 DEVICE FAILURE 138
799 SPUTUM DISCOLOURED 138
800 THERAPEUTIC RESPONSE SHORTENED 138
801 WITHDRAWAL SYNDROME 138
802 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 137
803 ACUTE CORONARY SYNDROME 137
804 LYMPHOEDEMA 137
805 PARAESTHESIA ORAL 137
806 PULMONARY ARTERIAL PRESSURE INCREASED 136
807 ACUTE HEPATIC FAILURE 135
808 HAEMORRHOIDAL HAEMORRHAGE 135
809 INJECTION SITE RASH 135
810 LOWER LIMB FRACTURE 135
811 DRY THROAT 134
812 HYPOTHERMIA 134
813 INCREASED TENDENCY TO BRUISE 133
814 POLYNEUROPATHY 133
815 ABNORMAL DREAMS 132
816 BREAST TENDERNESS 132
817 GLUCOSE TOLERANCE IMPAIRED 132
818 BASAL CELL CARCINOMA 131
819 DRUG WITHDRAWAL SYNDROME 131
820 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 131
821 INFARCTION 131
822 INJECTION SITE MASS 131
823 ASPHYXIA 130
824 AZOTAEMIA 130
825 CATHETER SITE INFECTION 130
826 DERMATITIS BULLOUS 130
827 ENDOCARDITIS 130
828 GLAUCOMA 130
829 HYPOPHOSPHATAEMIA 130
830 BODY HEIGHT DECREASED 129
831 DEVICE DIFFICULT TO USE 129
832 INTERNATIONAL NORMALISED RATIO DECREASED 129
833 MYOCARDITIS 129
834 PHOTOPHOBIA 129
835 SMALL INTESTINAL OBSTRUCTION 129
836 DYSLIPIDAEMIA 128
837 HOSPICE CARE 128
838 KNEE ARTHROPLASTY 128
839 PARKINSONISM 128
840 PERITONITIS BACTERIAL 128
841 SARS-COV-2 TEST POSITIVE 128
842 DRUG ABUSE 127
843 PNEUMONIA BACTERIAL 127
844 BLOOD GLUCOSE FLUCTUATION 126
845 MOTOR DYSFUNCTION 126
846 MYOPATHY 126
847 BRONCHOSPASM 125
848 DEVICE USE ERROR 125
849 EXTRASYSTOLES 125
850 MULTIPLE SCLEROSIS 125
851 OXYGEN CONSUMPTION INCREASED 125
852 PLATELET COUNT INCREASED 125
853 TENDERNESS 125
854 AORTIC ANEURYSM 124
855 BLOOD PRESSURE INADEQUATELY CONTROLLED 124
856 CREPITATIONS 124
857 HAIR COLOUR CHANGES 124
858 INFUSION SITE PRURITUS 124
859 INITIAL INSOMNIA 124
860 MOOD ALTERED 124
861 CATHETER SITE ERYTHEMA 123
862 DIABETIC NEUROPATHY 123
863 PRODUCT MONITORING ERROR 123
864 ANOSMIA 122
865 CYST 122
866 ANAL INCONTINENCE 121
867 BLOOD THYROID STIMULATING HORMONE INCREASED 121
868 CORONARY ARTERY STENOSIS 121
869 LOCAL SWELLING 121
870 METASTASES TO BONE 121
871 SLUGGISHNESS 121
872 CARDIAC FLUTTER 120
873 DRUG EFFECT INCOMPLETE 120
874 PRESCRIBED OVERDOSE 120
875 PRODUCT DISPENSING ERROR 120
876 PSYCHOTIC DISORDER 120
877 OBSTRUCTIVE SLEEP APNOEA SYNDROME 119
878 BONE MARROW FAILURE 118
879 BREAST MASS 118
880 HEPATITIS CHOLESTATIC 117
881 MYELODYSPLASTIC SYNDROME 117
882 NEPHROTIC SYNDROME 117
883 APATHY 116
884 APHONIA 116
885 BENIGN PROSTATIC HYPERPLASIA 116
886 INFUSION SITE REACTION 116
887 OSTEONECROSIS 116
888 BLOOD POTASSIUM ABNORMAL 115
889 CARDIAC OPERATION 115
890 CATHETER SITE HAEMORRHAGE 115
891 ERYSIPELAS 115
892 EXPIRED PRODUCT ADMINISTERED 115
893 EYE HAEMORRHAGE 115
894 HAEMORRHAGIC STROKE 115
895 IMMUNODEFICIENCY 115
896 TEMPERATURE INTOLERANCE 115
897 HYPERTENSIVE CRISIS 114
898 LIGAMENT SPRAIN 114
899 PRODUCT PRESCRIBING ISSUE 114
900 PSEUDOMONAS INFECTION 114
901 PULMONARY THROMBOSIS 114
902 QUALITY OF LIFE DECREASED 114
903 SKIN INFECTION 114
904 SPUTUM CULTURE POSITIVE 114
905 LARGE INTESTINE POLYP 113
906 PELVIC PAIN 113
907 PROSTATIC SPECIFIC ANTIGEN INCREASED 113
908 RED CELL DISTRIBUTION WIDTH INCREASED 113
909 SPINAL PAIN 113
910 SECRETION DISCHARGE 112
911 WOUND INFECTION 112
912 BEDRIDDEN 111
913 DEVICE EXPULSION 111
914 ILEUS 111
915 MUSCLE RIGIDITY 111
916 STAPHYLOCOCCAL SEPSIS 111
917 CATHETER SITE PAIN 110
918 ESSENTIAL HYPERTENSION 110
919 LIPASE INCREASED 110
920 MENSTRUATION IRREGULAR 110
921 PHARYNGITIS 110
922 PRODUCT STORAGE ERROR 110
923 THINKING ABNORMAL 110
924 EYE INFECTION 109
925 HEART RATE ABNORMAL 109
926 INGUINAL HERNIA 109
927 NODULE 109
928 PANCREATIC CARCINOMA 109
929 PHARMACEUTICAL PRODUCT COMPLAINT 109
930 PORTAL VEIN THROMBOSIS 109
931 PULMONARY HAEMORRHAGE 109
932 PURULENT DISCHARGE 109
933 INCREASED APPETITE 108
934 LEFT ATRIAL DILATATION 108
935 MANIA 108
936 PARKINSON^S DISEASE 108
937 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 107
938 ARTERIAL OCCLUSIVE DISEASE 107
939 JOINT DISLOCATION 107
940 RENAL PAIN 107
941 SINUS NODE DYSFUNCTION 107
942 SKIN ABRASION 107
943 SUPRAVENTRICULAR EXTRASYSTOLES 107
944 TENDONITIS 107
945 CAROTID ARTERY OCCLUSION 106
946 SCRATCH 106
947 HEPATIC CANCER 105
948 LACERATION 105
949 MYOSITIS 105
950 NEPHROPATHY TOXIC 105
951 ACUTE PRERENAL FAILURE 104
952 APNOEA 104
953 DEVICE MAINTENANCE ISSUE 104
954 DIVERTICULUM INTESTINAL 104
955 ESCHERICHIA INFECTION 104
956 HEMIPLEGIA 104
957 HYPERCAPNIA 104
958 MOUTH HAEMORRHAGE 104
959 NEEDLE ISSUE 104
960 PERIPHERAL VASCULAR DISORDER 104
961 DERMATITIS ALLERGIC 103
962 DILATATION VENTRICULAR 103
963 EAR DISCOMFORT 103
964 HAIR TEXTURE ABNORMAL 103
965 HEPATIC CYTOLYSIS 103
966 INTESTINAL ISCHAEMIA 103
967 MUSCLE STRAIN 103
968 PYELONEPHRITIS 103
969 RESPIRATION ABNORMAL 103
970 BLOOD CALCIUM INCREASED 102
971 BRONCHIAL SECRETION RETENTION 102
972 CHOLECYSTECTOMY 102
973 DISABILITY 102
974 GOITRE 102
975 HYPERCHOLESTEROLAEMIA 102
976 METABOLIC ALKALOSIS 102
977 MICTURITION URGENCY 102
978 MULTIPLE FRACTURES 102
979 NIPPLE PAIN 102
980 POOR VENOUS ACCESS 102
981 TENSION HEADACHE 102
982 VARICOSE VEIN 102
983 BLOOD CHLORIDE DECREASED 101
984 BRADYARRHYTHMIA 101
985 DENTAL CARIES 101
986 INTERVERTEBRAL DISC DEGENERATION 101
987 LARYNGITIS 101
988 SPINAL COMPRESSION FRACTURE 101
989 RENAL FUNCTION TEST ABNORMAL 100
990 TOOTH ABSCESS 100
991 ULCER HAEMORRHAGE 100
992 VENTRICULAR ARRHYTHMIA 100
993 CYTOKINE RELEASE SYNDROME 99
994 GASTROINTESTINAL PAIN 99
995 PELVIC FRACTURE 99
996 SYSTEMIC INFECTION 99
997 BACK INJURY 98
998 EMBOLIC STROKE 98
999 GASTROINTESTINAL INFECTION 98